Dr. Aparicio presented the work titled "Technomoral Entrepreneurship: Venture Formation and the Authorization of Germline Futures” at the Science and Democracy Network Annual Meeting in Potsdam’s Research Institute for Sustainability, Germany, on June 11.
Human germline gene editing remains highly contested, yet start-ups continue to emerge with the goal of creating gene-edited children. In this presentation, I argue that these founders engage in technomoral entrepreneurship: a strategy of authorization based on persuasion, through which entrepreneurs seek to become legitimate actors in the governance of technological futures.
